Market revenue in 2023 | USD 7,411.5 million |
Market revenue in 2030 | USD 19,736.6 million |
Growth rate | 15% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 50.97% in 2023. Horizon Databook has segmented the North America structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
North America's dominance in the global structural heart devices market in 2023 can be attributed to the region's advanced healthcare infrastructure and the high prevalence of Cardiovascular Diseases (CVDs). The U.S., in particular, experiences nearly 805,000 heart attacks each year, underscoring the substantial burden of cardiovascular disorders.
The geriatric population in the U.S. is a primary driver for this demand, with data indicating that Coronary Artery Bypass Graft Surgery (CABG) is the most common type of heart surgery, with over 300,000 successful procedures each year.
This high burden of CVDs necessitates the development and use of structural heart devices for treatment, thereby fueling market growth. Furthermore, the region's developed healthcare systems offer robust reimbursement mechanisms for approved structural heart devices, incentivizing hospitals and physicians to adopt these technologies.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America structural heart devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account